A Randomized, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against Placebo

NCT02172001 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study design not adequate

Conditions

Iron Deficiency Anemia

Interventions

DRUG: Iron isomaltoside 1000
DRUG: Natrium Chloride 0,9%

Sponsor

Pharmacosmos A/S